Armstrong Asphalt Tile

Armstrong World Industries manufactured asphalt floor tile for several decades of the twentieth century, producing a product that was widely installed in residential, commercial, and industrial settings across the United States. Sold under the Armstrong brand name, asphalt tile became one of the most common hard-surface flooring materials of the mid-century era. What was not disclosed to workers and building occupants at the time was that many formulations of this tile contained chrysotile asbestos — a fibrous mineral now recognized as a human carcinogen capable of causing mesothelioma, lung cancer, and asbestosis decades after initial exposure.

Product Description

Armstrong asphalt tile was produced from approximately 1931 through 1972, spanning a period during which synthetic flooring materials were rapidly replacing wood, linoleum, and other traditional surfaces. The tiles were manufactured as rigid, square units — typically nine inches or twelve inches per side — designed for direct adhesion to concrete slabs and subfloors in basements, kitchens, commercial corridors, schools, hospitals, factories, and public buildings.

Armstrong World Industries, headquartered in Lancaster, Pennsylvania, was one of the dominant flooring manufacturers in the country throughout the twentieth century. The company’s asphalt tile line competed with similar products from other major manufacturers, and its distribution network ensured widespread installation across virtually every building type and region. The product remained in production until asbestos began to be phased out of flooring formulations in the early 1970s, as regulatory and scientific scrutiny of asbestos-containing building materials intensified.

Because asphalt tile was extremely durable under normal conditions, a significant quantity of pre-1972 Armstrong asphalt tile remains in place in existing structures today. Intact tile that has not been disturbed poses a lower immediate risk than friable asbestos materials, but any activity that cuts, sands, scrapes, or otherwise damages the tile can release fibers into the breathing zone.

Asbestos Content

Armstrong asphalt tile contained chrysotile asbestos, the most commercially prevalent form of asbestos used in the United States during the twentieth century. Chrysotile, sometimes referred to as white asbestos, is a serpentine mineral characterized by long, curly fibers. Although industry representatives historically argued that chrysotile was less hazardous than amphibole varieties such as crocidolite or amosite, the scientific and regulatory consensus — reflected in OSHA standards, AHERA regulations, and determinations by the International Agency for Research on Cancer — classifies all forms of asbestos, including chrysotile, as known human carcinogens with no established safe level of exposure.

In asphalt tile, chrysotile asbestos served as a reinforcing agent, contributing to the tile’s structural integrity, dimensional stability, and resistance to cracking under load and temperature variation. The asbestos fibers were blended with asphalt binders, mineral fillers, and pigments during the manufacturing process, becoming an integral component of the finished product rather than a surface coating. This integration meant that intact tile generally did not shed fibers under ordinary use, but disruption of the material — whether during installation, removal, or renovation — could release respirable chrysotile fibers.

How Workers Were Exposed

Industrial workers employed in building maintenance, renovation, and demolition were among those most directly exposed to asbestos fibers from Armstrong asphalt tile. Exposure pathways were closely tied to the physical work performed on or around the tile.

Installation. Workers who cut asphalt tile to fit irregular spaces, door frames, or irregular floor layouts did so using hand saws, scoring tools, or mechanical cutting equipment. These cutting operations generated airborne dust containing chrysotile fibers. Installation workers frequently performed this work in enclosed, poorly ventilated spaces — basements, utility rooms, and corridors — where fibers could accumulate without adequate dispersal.

Removal and renovation. Demolition and renovation activity involving pre-1972 asphalt tile presented significant exposure risk. Removing aged tile from concrete substrates often required chipping, scraping, or grinding operations that broke the tile into fragments and disturbed the asbestos-containing matrix. Power grinding of adhesive residue left behind after tile removal could generate particularly dense concentrations of airborne dust.

Maintenance and repair. Industrial facilities with large areas of asphalt tile flooring required ongoing maintenance. Workers who sanded, buffed, or repaired damaged tile sections without appropriate respiratory protection could inhale fibers released from abraded tile surfaces.

Secondary exposure. Workers in adjacent trades and bystanders present during cutting or removal operations could be exposed to fibers even if they were not directly handling the tile themselves. Ventilation systems in large industrial facilities could also distribute asbestos-laden dust beyond the immediate work area.

Litigation records document that workers in these roles often had no knowledge that the flooring materials they handled contained asbestos. Plaintiffs alleged that Armstrong World Industries was aware of the potential health hazards associated with asbestos-containing products for years or decades before adequate warnings were provided to end users and workers, and that this failure to warn contributed directly to occupational disease.

Documented Trust Fund / Legal Options

Armstrong World Industries filed for Chapter 11 bankruptcy protection in 2000, citing mounting asbestos litigation liability. The company reorganized and emerged from bankruptcy in 2006. Armstrong World Industries did not establish a Section 524(g) asbestos trust fund as part of its reorganization. Unlike many asbestos defendants whose bankruptcy proceedings resulted in the creation of dedicated compensation trusts, Armstrong’s restructuring did not produce a trust through which asbestos claimants can file administrative claims.

As a result, individuals who developed mesothelioma, lung cancer, asbestosis, or other asbestos-related diseases after exposure to Armstrong asphalt tile must pursue compensation through civil litigation rather than through a trust fund claims process.

Litigation records document numerous lawsuits brought by workers and their families alleging that exposure to Armstrong asphalt tile and other Armstrong asbestos-containing products caused serious and fatal disease. Plaintiffs alleged negligence, failure to warn, and product liability on the part of Armstrong and related corporate entities.

Who may have legal options:

• Industrial workers who installed, removed, repaired, or worked near Armstrong asphalt tile during its production years of 1931–1972
• Workers who performed renovation or demolition in buildings where Armstrong asphalt tile was installed, particularly in the absence of appropriate hazard identification and respiratory protection
• Family members of exposed workers who developed secondary exposure through contact with work clothing and equipment
• Surviving family members of deceased workers whose illness and death were causally connected to asbestos exposure

Individuals who believe they have been exposed to Armstrong asphalt tile and have received a diagnosis of an asbestos-related disease are encouraged to consult with an attorney experienced in asbestos litigation. The latency period for mesothelioma and related diseases — typically twenty to fifty years between exposure and diagnosis — means that workers exposed during mid-century installations may be receiving diagnoses today. Statutes of limitations for asbestos claims vary by state and generally begin running from the date of diagnosis rather than the date of exposure; prompt legal consultation is therefore important.

This article is provided for informational purposes based on documented product history, regulatory records, and litigation filings. It does not constitute legal or medical advice.